Quick answer
Teva Pharmaceutical Industries Limited (TEVA) reported diluted EPS of $-0.49 for the quarter ended 2026-06-30, in a 10-Q filed with the SEC on 2026-07-29. Its last four 10-Q/10-K filings were on 2026-07-29, 2026-04-29, 2026-02-03, 2025-11-05.
Data as of 2026-07-29. Source: SEC EDGAR XBRL company facts (10-K/10-Q filings)
| Period end | Period | Form | SEC filing date | Diluted EPS |
|---|---|---|---|---|
| 2026-06-30 | Quarter | 10-Q | 2026-07-29 | $-0.49 |
| 2026-03-31 | Quarter | 10-Q | 2026-04-29 | $0.31 |
| 2025-12-31 | Full year | 10-K | 2026-02-03 | $1.21 |
| 2025-09-30 | Quarter | 10-Q | 2025-11-05 | $0.37 |
| 2025-06-30 | Quarter | 10-Q | 2025-07-30 | $0.24 |
| 2025-03-31 | Quarter | 10-Q | 2025-05-07 | $0.18 |
| 2024-12-31 | Full year | 10-K | 2025-02-05 | $-1.45 |
| 2024-09-30 | Quarter | 10-Q | 2024-11-06 | $-0.39 |
| 2024-06-30 | Quarter | 10-Q | 2024-07-31 | $-0.75 |
| 2024-03-31 | Quarter | 10-Q | 2024-05-08 | $-0.12 |
| 2023-12-31 | Full year | 10-K | 2024-02-12 | $-0.50 |
| 2023-09-30 | Quarter | 10-Q | 2023-11-09 | $0.07 |
| 2023-06-30 | Quarter | 10-Q | 2023-08-02 | $-0.77 |
| 2023-03-31 | Quarter | 10-Q | 2023-05-10 | $-0.18 |
| 2022-12-31 | Full year | 10-K | 2023-02-10 | $-2.12 |
| 2022-12-31 | Quarter | 10-K | 2024-02-12 | $-1.17 |
Related
- TEL earnings report dates and EPS history (Te Connectivity Plc)
- TEM earnings report dates and EPS history (Tempus AI, Inc.)
- TER earnings report dates and EPS history (Teradyne, Inc.)
- TFC earnings report dates and EPS history (Truist Financial Corporation)
- TGT earnings report dates and EPS history (Target Corporation)
- TGTX earnings report dates and EPS history (Tg Therapeutics, Inc.)
- THC earnings report dates and EPS history (Tenet Healthcare Corp)
- THG earnings report dates and EPS history (Hanover Insurance Group, Inc.)
Last updated 2026-10-16. Data only, not financial or tax advice.